Articles | EuroIntervention

• Mar 20, 2009

Incidence, patient characteristics and predictors of aborted myocardial infarction in patients undergoing primary PCI: prospective study comparing pre- and in-hospital abciximab pretreatment

Hassan A, Jukema W, van der Laarse A, Hasan-Ali H, Wolterbeek R, van der Kley F, Spano F, Atsma D, Schalijv M

free

• Mar 20, 2009

The use of self-expanding stents in coronary bifurcations and beyond: a paradigm revisited

Jilaihawi H, Farah B, Laborde J-C

free

• Mar 20, 2009

Innovations in Cardiovascular Interventions 2008 – Technology Parade

Beyar R, Lotan C

free

• Jan 20, 2009

PUBMED/MEDLINE indexing

Serruys PW

free

• Jan 20, 2009

The gender paradox

Presbitero P

free

• Jan 20, 2009

Observational studies of drug-eluting stents – some are more equal than others.

Austin D, Oldroyd K, Pell J

free

• Jan 20, 2009

As time goes on... reflections. A greeting and ongoing wish-list from your EAPCI

Wijns W

free

• Jan 20, 2009

Meeting report. ESC Forum on Drug Eluting Stents, European Heart House, Nice, 27-28 September 2007

Daemen J, Simoons M, Wijns W, Bagust A, Bos G, Bowen J, Braunwald E, Camenzind E, Chevalier B, Di Mario C, Fajadet J, Gitt A, Guagliumi G, Hillege H, James S, Jüni P, Kastrati A, Kloth S, Kristensen SD, Krucoff M, Legrand V, Pfisterer M, Rothman M, Serruys PW, Silber S, Steg G, Tariah I, Wallentin L, Windecker S

free

• Jan 20, 2009

Effect of percutaneous mitral repair with the MitraClip® device on mitral valve area and gradient

Herrmann H, Kar S, Siegel R, Fail P, Loghin C, Lim S, Hahn R, Rogers J, Bommer W, Wang A, Berke A, Lerakis S, Kramer P, Chiu Wong S, Foster E, Glower D, Feldman T

free

• Jan 20, 2009

Assessment of the absorption process following bioabsorbable everolimus-eluting stent implantation: temporal changes in strain values and tissue composition using intravascular ultrasound radiofrequency data analysis. A substudy of the ABSORB clinical trial.

Garcia-Garcia H, Gonzalo N, Pawar R, Kukreja N, Dudek D, Thuesen L, Ormiston J, Regar E, Serruys PW

free

• Jan 20, 2009

Twelve month clinical and angiographic outcome after stenting of unprotected left main coronary artery stenosis with paclitaxel-eluting stents – results of the multicentre FRIEND registry

Carrié D, Eltchaninoff H, Lefèvre T, Silvestri M, Levy G, Maupas E, Brunel P, Fajadet J, Le Breton H, Gilard M, Blanchard D, Glatt B

free

• Jan 20, 2009

Long-term follow-up of percutaneous coronary intervention of unprotected left main lesions with drug eluting stents: predictors of clinical outcome

Pavei A, Oreglia J, Martin G, Tousek P, Sharif F, Farah B, Sauguet A, Fajadet J

free

• Jan 20, 2009

The relative safety and efficacy of bare-metal and drug-eluting stents in low and high-risk patient subsets. An epidemiological analysis of three sequential cohorts of consecutive all comers (n=6129)

Daemen J, van Twisk P-H, Kukreja N, van Domburg R, Boersma E, de Jaegere P, Serruys PW

free

• Jan 20, 2009

Dual quantitative coronary angiography: a novel approach to quantify intracoronary thrombotic burden

Aleong G, Vaqueriza D, del Valle R, Garcia H, Hernandez R, Alfonso F, Jiménez-Quevedo P, Banuelos C, Macaya C, Escaned J

free

• Jan 20, 2009

Initial evidence for the return of coronary vasoreactivity following the absorption of bioabsorbable magnesium alloy coronary stents

Ghimire G, Spiro J, Kharbanda R, Roughton M, Barlis P, Mason M, Ilsley C, Di Mario C, Erbel R, Waksman R, Dalby M

free